Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 146307-51-9 | MDL No. : | MFCD17015041 |
Formula : | C13H23NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RKOQMDUDKCMVFW-UHFFFAOYSA-N |
M.W : | 257.33 | Pubchem ID : | 17859336 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.85 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 68.29 |
TPSA : | 64.63 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.41 cm/s |
Log Po/w (iLOGP) : | 3.05 |
Log Po/w (XLOGP3) : | 2.06 |
Log Po/w (WLOGP) : | 2.24 |
Log Po/w (MLOGP) : | 1.58 |
Log Po/w (SILICOS-IT) : | 1.37 |
Consensus Log Po/w : | 2.06 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.34 |
Solubility : | 1.18 mg/ml ; 0.0046 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.05 |
Solubility : | 0.231 mg/ml ; 0.000899 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.12 |
Solubility : | 1.96 mg/ml ; 0.00762 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.16 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With triethylamine In dichloromethane at 20℃; for 2.16667 h; Cooling with ice | Amine (132 g, 401 mmol) was suspended in dichloromethane (1000 ml) under ice-cooling. Triethylamine (123 ml, 882 mmol) and (Boc)2O (101 ml, 440 mmol) were sequentially added thereto and stirred for 10 minutes. After that, the mixture was stirred at room temperature for 2 hours and the solvent was removed. The residue was poured into aqueous citric acid (citric acid monohydrate 50 g in water 400 ml) to become pH4 and extracted with ethyl acetate. The organic layer was washed with water and dried over magnesium sulfate anhydrous. The solvent was removed under reduced pressure to quantitatively give the target compound.1H-NMR (DMSO-d6) δ ppm: 1.06-1.25 (m, 2H), 1.25-1.43 (m, 2H), 1.37 (s, 9H), 1.75-1.94 (m, 4H), 2.19 (tt, 1H, J=11.7, 3.9 Hz), 3.07-3.24 (m, 1H), 3.58 (s, 3H), 6.74 (d, 1H, J=6.6 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1 h; | Step 1 trans-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate To a suspension of trans-methyl 4-aminocyclohexanecarboxylate hydrochloride (1.5 g, 7.7 mmol) in DCM (80 mL) was added DIEA (4 g, 31mmol) and (Boc)20 (3 g, 13.9 mmol) at room temperature. The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was concentrated in vacuum to give crude product. The crude product was purified by silica gel chromatography (PE / EtOAc = 8 : 1 to 3 : 1) to give trans-methyl 4-((iert-butoxycarbonyl)amino)cyclohexanecarboxylate (1.7 g, yield 86percent) as a white solid. 1H NMR (400 MHz, Methanol-d4) δ 4.38 (br, 1H), 3.66 (s, 3H), 3.47- 3.40 (m, 1H), 2.22-2.19 (m, 1H), 2.07-1.98 (m, 4H), 1.56-1.50 (m, 2H), 1.43 (s, 9H), 1.15-1.12 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.2% | at 100℃; for 16 h; Inert atmosphere | In nitrogen atmosphere, to a solution of trans- 1,4-cyclohexane-dicarboxylic acid monomethyl ester (A3-1) (lOOg, 0.538mol, l .Oeq) and triethylamine (57.4g, 0.568mol, 1.055eq) in t-butyl alcohol (lOOOmL) was added dropwise diphenylphosphoryl azide (155g, 0.563mol, 1.047eq) at room temperature. The mixture was refluxed over 16hrs. Upon completion by TLC, the mixture was then cooled and concentrated. Water (lOOOmL) was added, and the mixture was extracted three times with MTBE. Then the organic layer was washed with saturated sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate, concentrated and purified by silica gel column chromatography to give compound A3 -2 as an off-white powder (53g, yield 39.2percent). MS-ESI:[M+1]+: 257.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | at 60℃; for 1 h; | To (frans)-4-(methoxycarbonyl)cyclohexanecarboxylic acid (2.5 mg, 13 mmol) in tert- butanol (25 mL) was added diphenyl phosphorazidate (3.88 g, 14 mmol) and triethylamine (1 .97 mL, 14 mmol). The mixture was heated at 60 °C for 1 h and then at reflux overnight. After cooling to room temperature, the mixture was quenched into ice water and extracted with EtOAc. The combined organics were washed with sat. NaHC03 and brine, dried over Na2S04, filtered, and concentrated. The residue was dissolved in MeOH (6 mL) and to this was added water (18 mL). After stirring for ca. 1 h on ice, the resulting solid was collected by filtration, and washed with 3:1 water:MeOH, and hexanes to give the title compound as a white solid (2.32 g, 67percent yield). 1H NMR (400 MHz, CD3SOCD3) δ 1 .05-1 .20 (m, 2 H), 1 .25-1 .44 (m, 1 1 H), 1 .72- 1 .91 (m, 4 H), 2.17 (tt, J = 12, 3 Hz, 1 H), 3.06-3.21 (m, 1 H), 3.56 (s, 3 H), 6.72 (d, J = 8 Hz, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; | A suspension of LiAlH4(9.0g, 0.236mol, 1.12eq) in THF (500mL) was cooled to 0°C in ice-bath, and then added a solution of compound A3-2 (54.3g, 0.21 lmol, l .Oeq) in THF (200mL) while keeping the temperature below 10°C. The reaction mixture was stirred overnight at room temperature, and then quenched with sodium sulfate decahydrate (27g) at 15°C to 25°C, filtered and the filtrate was concentrated to give compound A3-3 as a white powder (43g, yield 89percent). MS-ESI:[M+1]+: 229.1 |
89% | With sodium tetrahydroborate; calcium chloride In tetrahydrofuran; ethanol at 20℃; | To a solution of (frans)-methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate (Intermediate 18A) (1 .5 g, 5.8 mmol) in EtOH (24 mL) and THF (2.7 mL), cooled on ice, was added calcium chloride (1 .29 g, 1 1 .7 mmol) portion wise to give a milky suspension. NaBH4 (882 mg, 23.3 mmol) was then added portion wise over ca. 25 min and the reaction was stirred on ice for 1 h. The bath was removed and the mixture was allowed to stir at room temperature overnight. The reaction was cooled to 10 °C and to this was added 5percent aqueous K2CO3 (5.4 mL) dropwise, to give a pH of ca. 1 1 . A white precipitate formed and was isolated by filtration. The solid was stirred with EtOAc (50 mL) and water (14 mL). The layers were separated and the organic layer was washed with 0.5 M aqueous HCI (5 mL), water and brine, dried over MgS04, filtered, and concentrated to give the title compound (474 mg) as a white solid. The initial filtrate was concentrated, then dilute with saturated aqueous NH4CI and extracted with EtOAc (3X). Combined organics were washed with brine and dried over Na2SC>4, filtered, and concentrated to give the title compound (724 mg) as a white solid. Total isolated product was 1 .1 9 g (89percent yield). 1H NMR (400 MHz, CD3SOCD3) δ 0.78-0.93 (m, 2 H), 1 .01 -1 .15 (m, 2 H), 1 .35 (s, 9 H), 1 .64-1 .80 (m, 4 H), 3.10 (d, J = 8 Hz, 1 H), 3.16 (t, J = 6 Hz, 2 H), 4.33 (t, J = 5 Hz, 1 H), 6.64 (d, J = 8 Hz, 1 H). |
[ 676371-64-5 ]
Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate
Similarity: 0.94
[ 303752-38-7 ]
3-(Boc-amino)bicyclo[1.1.1]pentane-1-carboxylic Acid
Similarity: 0.91
[ 223131-01-9 ]
tert-Butyl (cis-4-(hydroxymethyl)cyclohexyl)carbamate
Similarity: 0.84
[ 239074-29-4 ]
tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate
Similarity: 0.84
[ 880166-10-9 ]
Methyl 1-((tert-butoxycarbonyl)amino)cyclobutanecarboxylate
Similarity: 0.84
[ 676371-64-5 ]
Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate
Similarity: 0.94
[ 303752-38-7 ]
3-(Boc-amino)bicyclo[1.1.1]pentane-1-carboxylic Acid
Similarity: 0.91
[ 85909-04-2 ]
Methyl 4-((tert-butoxycarbonyl)amino)butanoate
Similarity: 0.88
[ 912444-90-7 ]
1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate
Similarity: 0.86
[ 124443-68-1 ]
1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate
Similarity: 0.86
[ 676371-64-5 ]
Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate
Similarity: 0.94
[ 85909-04-2 ]
Methyl 4-((tert-butoxycarbonyl)amino)butanoate
Similarity: 0.88
[ 912444-90-7 ]
1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate
Similarity: 0.86
[ 124443-68-1 ]
1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate
Similarity: 0.86
[ 142851-03-4 ]
Ethyl N-Boc-piperidine-4-carboxylate
Similarity: 0.84
[ 676371-64-5 ]
Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate
Similarity: 0.94
[ 303752-38-7 ]
3-(Boc-amino)bicyclo[1.1.1]pentane-1-carboxylic Acid
Similarity: 0.91
[ 85909-04-2 ]
Methyl 4-((tert-butoxycarbonyl)amino)butanoate
Similarity: 0.88
[ 223131-01-9 ]
tert-Butyl (cis-4-(hydroxymethyl)cyclohexyl)carbamate
Similarity: 0.84
[ 239074-29-4 ]
tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate
Similarity: 0.84